Table 1.

Somatic variants present in our patient’s leukemic cells at diagnosis

GeneCoding DNA changePredicted protein changeVariant classificationVariant allele frequency
CEBPA c.68dupC p.H24Afs Frame shift insertion 0.5052 
TET2 c.2101C>T p.Q701* Nonsense mutation 0.5625 
TET2 c.3812dupG p.C1271fs*29 Frame shift insertion 0.3267 
KCNT2 c.664C>T p.R222* Nonsense mutation 0.4286 
IKBKE c.365G>A p.G122D Missense mutation 0.1667 
KDR c.659-1G>T NA Splice site 0.1064 
KMT2C c.2591A>G p.E864G Missense mutation 0.2333 
PDZRN4 c.2994G>T p.K998N Missense mutation 0.4138 
GeneCoding DNA changePredicted protein changeVariant classificationVariant allele frequency
CEBPA c.68dupC p.H24Afs Frame shift insertion 0.5052 
TET2 c.2101C>T p.Q701* Nonsense mutation 0.5625 
TET2 c.3812dupG p.C1271fs*29 Frame shift insertion 0.3267 
KCNT2 c.664C>T p.R222* Nonsense mutation 0.4286 
IKBKE c.365G>A p.G122D Missense mutation 0.1667 
KDR c.659-1G>T NA Splice site 0.1064 
KMT2C c.2591A>G p.E864G Missense mutation 0.2333 
PDZRN4 c.2994G>T p.K998N Missense mutation 0.4138 

This list is focused on genes mutated in at least 1 hematopoietic neoplasm per the COSMIC database. Just those somatic variants that are predicted to have high impact on protein function (eg, missense, nonsense, frame shifts, and splice site variants) are included.

or Create an Account

Close Modal
Close Modal